Medical Research Council Clinical Trials Unit

Medical Research Council Clinical Trials Unit (MRC Clinical Trials Unit) is a privately held pharmaceutical company. The company is focused in clinical research and specializes in cancer and HIV/AIDS. The company also work outs its research in the therapeutic areas including arthritis and musculoskeletal, blood transfusion, dermatology, diabetes, human prion disease, mental health, multiple sclerosis and pain management, respiratory disease, tuberculosis. It has collaborations with other pharma companies and research institutes for the further development of its clinical trials and research activities. Recently, the company has done some important changes to the RADICALS trial along with systematic review, or meta-analysis. MRC Clinical Trials Unit is headquartered in London, the UK.

Street: 
222 Euston Road
City: 
London
Postcode: 
NW1 2DA
Federal State : 
United Kingdom
WebSite: 
www.ctu.mrc.ac.uk

Company Index Score

Current Index Score Historical Index Score
  • Medical Research Council Clinical Trials Unit currently scores 50 % in the index.
  • Medical Research Council Clinical Trials Unit is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Medical Research Council Clinical Trials Unit is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets